Articles From: Elbit Systems of America Awarded Approximately $29 Million Contract to Provide Logistics Support to the United States Air Force's F-16 Head-Up Displays to FICO World 2014 Draws Sellout Audience in San Diego to Explore the New Customer Imperative


Elbit System of America gives new life to existing F-16 HUD while improving reliability and maintainability TALLADEGA, Alabama , November 11, 2014 /PRNewswire/ -- Elbit Systems of America company, a wholly owned subsidiary of Elbit Systems Ltd., was awarded a five-year, firm-fixed price contract valued at approximately $29 million by the United States Air Force (USAF) for logistics support of USAF's F-16 head-up display (HUD) electric module assemblies.
Sign-up for Elbit Systems of America Awarded Approximately $29 Million Contract to Provide Logistics Support to the United States Air Force's F-16 Head-Up Displays investment picks
HAIFA, Israel , November 11, 2014 /PRNewswire/ -- Elbit Systems Ltd.
Sign-up for Elbit Systems U.S. Subsidiary Awarded Approximately $29 Million Contract to Provide Logistics Support to the United States Air Force's F-16 Head-Up Displays investment picks
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced detailed results from AbbVie’s open-label, Phase 2b PEARL-I study in patients with genotype 4 (GT4) chronic hepatitis C virus (HCV). PEARL-I studied AbbVie’s all-oral, interferon-free investigational treatment combining two direct-acting antivirals (ABT-450/ritonavir and ombitasvir) with or without ribavirin (RBV) for 12 weeks in non-cirrhotic adult patients with chronic genotype 1b (GT1b) and GT4 hepatitis C virus (HCV) infection.
Sign-up for Enanta Announces Results from Phase 2b PEARL-I Study in Genotype 4 Chronic Hepatitis C Patients at The Liver Meeting 2014® investment picks
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced at The Liver Meeting ® 2014 results from studies in chronic hepatitis C virus (HCV) patients with human immunodeficiency virus type 1 (HIV-1) co-infection (TURQUOISE-I) and liver transplant recipients (CORAL-I). New, detailed results from part one of the Phase 2 portion of AbbVie’s Phase 2/3 open-label study, TURQUOISE-I, showed that patients co-infected with genotype 1 (GT1) HCV and HIV-1 receiving AbbVie’s investigational treatment and ribavirin (RBV) for 12 weeks or 24 weeks achieved a sustained virologic response rate 12 weeks post-treatment (SVR 12 ) of 93.5 percent (n=29/31) and 90.6 percent (n=29/32), respectively.
Sign-up for Enanta Announces Results from TURQUOISE-I Study in Chronic Hepatitis C Patients with HIV-1 Co-infection and from the CORAL-I Study In Liver Transplant Recipients at The Liver Meeting 2014® investment picks
Ensco plc (NYSE: ESV) announced today that its Board of Directors has declared a regular quarterly cash dividend of US$0.75 per Class A ordinary share payable on 19 December 2014.
Sign-up for Ensco plc Announces Cash Dividend investment picks
Enterprise Products Partners L.P. (NYSE:EPD) today announced that W.
Sign-up for Enterprise Products Partners to Participate in Jefferies Global Energy Conference investment picks
2014/11/11
New "Household Direct" (HD) Products Help Marketers Adapt to Changing Compliance Challenges ATLANTA , Nov.
Sign-up for Equifax Expands Marketing Product Offerings for Bank Marketers investment picks
ATLANTA , Nov.
Sign-up for Equifax To Visit Investors In San Francisco investment picks
Datapipe will offer hybrid IT solutions including managed AWS within Equinix data centers REDWOOD CITY, Calif.
Sign-up for Equinix and Datapipe Collaborate to Deliver Hybrid IT Solutions for Enterprises investment picks
The Rosen Law Firm announces that it is investigating potential securities claims against Vivint Solar, Inc. (NYSE: VSLR) resulting from allegations that the Company may have issued materially misleading business information to the investing public in connection with its initial public offering on September 30, 2014.
Sign-up for EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Vivint Solar, Inc. - VSLR investment picks
2014/11/11
NEW YORK, Nov.
Sign-up for EQUITY ALERT: The Rosen Law Firm Files Securities Fraud Class Action Against SandRidge Energy, Inc. - SD investment picks
Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, today announced it will host an investor event and live webcast to discuss the ETC-1002 development program, including the Phase 2b ETC-1002-008 results announced last month.
Sign-up for Esperion Therapeutics to Host and Webcast Live Investor Event investment picks
2014/11/11
By Sara Sjolin, MarketWatch Stoxx 600 could see as much as a 30% rally LONDON (MarketWatch) -- U.S. stocks are at record levels and Japanese equities have just rallied to seven-year highs -- searching for a new market to take you higher?
Sign-up for European stocks could be gearing up for a big rally investment picks
2014/11/11
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- With no major data releases on tap, investors in Europe focused on a raft of upbeat earnings reports on Tuesday, sending the region's major benchmarks higher for a second straight day.
Sign-up for European stocks lifted by earnings; Vodafone, Henkel climb investment picks
2014/11/11
NANJING , China , Nov.
Sign-up for Ever-Glory Schedules Third Quarter 2014 Earnings Release and Conference Call investment picks
Acquires DoctorDirectory, further strengthening ROI-based marketing solutions for the professional market NEW YORK , Nov.
Sign-up for Everyday Health Reports Third Quarter 2014 Financial Results investment picks
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announces that its spine division has launched Octane® Elevate, a Poly Ether Ether Ketone (PEEK) spacer system, at the North American Spine Society Annual Meeting (NASS). With the introduction of Octane Elevate, an innovative, self-distracting lumbar fusion device, surgeons can restore disc height while addressing various anatomical conditions and degrees of degeneration.
Sign-up for Exactech Launches Octane® Elevate Peek Spacer System For Lumbar Interbody Fusion Procedures investment picks
Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M.
Sign-up for Exelixis to Present at the Stifel 2014 Healthcare Conference on Tuesday, November 18 investment picks
2014/11/11
EXFO Enhances 40G/100G lab testing capabilities to allow NEMs and carrier labs to fully qualify and test 100G network elements Canada NewsWire Extended multi-stage ODUmuxing and SONET/SDH client mappings now available on the FTB/IQS-85100G Packet Blazer series QUEBEC CITY , Nov.
Sign-up for EXFO Enhances 40G/100G lab testing capabilities to allow NEMs and carrier labs to fully qualify and test 100G network elements investment picks
2014/11/11
Extended multi-stage ODUmuxing and SONET/SDH client mappings now available on the FTB/IQS-85100G Packet Blazer series QUEBEC CITY, Nov.
Sign-up for EXFO Enhances 40G/100G lab testing capabilities to allow NEMs and carrier labs to fully qualify and test 100G network elements investment picks
2014/11/11
Among the more than 100 experts surveyed in the Zillow Home Price Expectations Survey, a majority said they don't expect the housing market to normalize for at least three more years.
Sign-up for Experts: First-Time Homebuyers' Weak Finances Holding Back Housing Market investment picks
The latest figures from Texas Workforce Commission show a fantastically low unemployment rate of 4% and hundreds of job opportunities in Abilene, Texas – ground zero for prime properties being scouted by Taylor Consulting Inc. (OTCBB:TAYO) ahead of a population boom created by oil and gas production in the Permian Basin in West Texas.
Sign-up for Falling Unemployment, Rising Job Opportunities Keep TAYO Hot for Abilene Real Estate investment picks
PITTSBURGH , Nov.
Sign-up for Federated Investors' Closed-End Municipal Funds Declare Monthly Dividends investment picks
The law firm of Federman & Sherwood has initiated an investigation into Swift Energy Company (NYSE: SFY) with respect to possible violations of federal securities laws.
Sign-up for Federman & Sherwood Investigates Swift Energy Company For Possible Violations of Federal Securities Laws investment picks
1,200 attendees from 45 countries share new ideas for acquiring, serving and retaining customers profitably SAN DIEGO , Nov.
Sign-up for FICO World 2014 Draws Sellout Audience in San Diego to Explore the New Customer Imperative investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Elbit Systems of America Awarded Approximately $29 Million Contract to Provide Logistics Support to the United States Air Force's F-16 Head-Up Displays to FICO World 2014 Draws Sellout Audience in San Diego to Explore the New Customer Imperative
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent